View in EDS

Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.

Saved in:
Bibliographic Details
Title: Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.
Authors: Fernandes LM; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States., Tresemer J; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States., Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, United States., Rios JJ; Center for Pediatric Bone Biology and Translational Research, Scottish Rite for Children, Dallas, TX, United States.; McDermott Center for Human Growth and Development, Dallas, TX, United States., Scallan JP; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Dellinger MT; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.; Department of Surgery, UT Southwestern Medical Center, Dallas, TX, United States.
Source: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Sep 25; Vol. 11, pp. 1276333. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37842094
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fernandes+LM%22">Fernandes LM</searchLink>; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Tresemer+J%22">Tresemer J</searchLink>; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Rios+JJ%22">Rios JJ</searchLink>; Center for Pediatric Bone Biology and Translational Research, Scottish Rite for Children, Dallas, TX, United States.; McDermott Center for Human Growth and Development, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Scallan+JP%22">Scallan JP</searchLink>; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Dellinger+MT%22">Dellinger MT</searchLink>; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.; Department of Surgery, UT Southwestern Medical Center, Dallas, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101630250%22">Frontiers in cell and developmental biology</searchLink> [Front Cell Dev Biol] 2023 Sep 25; Vol. 11, pp. 1276333. <i>Date of Electronic Publication: </i>2023 Sep 25 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101630250 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-634X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296634X%22">2296634X </searchLink><i>NLM ISO Abbreviation: </i>Front Cell Dev Biol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37842094
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fcell.2023.1276333
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1276333
    Titles:
      – TitleFull: Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fernandes LM
      – PersonEntity:
          Name:
            NameFull: Tresemer J
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Rios JJ
      – PersonEntity:
          Name:
            NameFull: Scallan JP
      – PersonEntity:
          Name:
            NameFull: Dellinger MT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 09
              Text: 2023 Sep 25
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2296-634X
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in cell and developmental biology
              Type: main
ResultId 1